Clearpoint Neuro Inc Stock (CLPT) Financials Data
*All numbers in millions
| Period End Date | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues | 10.98%12.08 | 10.88 | 12.13 | 10.41 | 8.86 |
| Cost Of Revenue | 20.29%5.02 | 4.17 | 4.37 | 4.01 | 3.26 |
| Gross Profit | 5.20%7.06 | 6.71 | 7.76 | 6.40 | 5.60 |
30.84%3.84 | 5.55 | 5.00 | 5.44 | - | |
| Selling, General, and Administrative | 30.84%3.84 | 5.55 | 5.00 | 5.44 | - |
| Research and Development | 13.26%4.02 | 4.63 | 4.52 | 3.24 | - |
| Operating Income/Loss | 38.19%-6.33 | -10.24 | -8.48 | -7.05 | -5.28 |
| Income/Loss From Continuing Operations Before Tax | 34.38%-7.46 | -11.38 | -9.54 | -7.78 | -5.88 |
| Income Tax Expense/Benefit, Deferred | -0.02 | - | - | - | - |
| Income Tax Expense/Benefit | 89.47%-0.00 | -0.04 | 0.01 | 0.00 | 0.01 |
34.20%-7.46 | -11.34 | -9.55 | -7.79 | -5.89 | |
| Attributable To Parent | 34.20%-7.46 | -11.34 | -9.55 | -7.79 | -5.89 |
| Basic Average Shares | 2.71%30.98 | 30.17 | 29.55 | - | 28.43 |
| Diluted Average Shares | 2.71%30.98 | 30.17 | 29.55 | - | 28.43 |
| Basic Earnings Per Share | 36.84%-0.24 | -0.38 | -0.32 | - | -0.21 |
| Diluted Earnings Per Share | 36.84%-0.24 | -0.38 | -0.32 | - | -0.21 |